Skip to Content
  • Previous Rank39
  • Revenues ($M)$71,890
  • Revenue Percent Change2.6%
  • Profits ($M)$16,540
  • Profits Percent Change7.3%
  • Assets ($M)$141,208
  • Employees126,400
  • Market Value — as of March 31, 2017 ($M)$337,642

As the world’s biggest health care products company, Johnson & Johnson has massive scope: a sampling of its products includes Benadryl, Band-Aids, Neutrogena, Tylenol, Motrin, and Listerine. How do you boost something that’s already big? Acquisitions and revenue growth (notably in beauty products). While domestic sales rose 6%, international sales decreased about 1% thanks to divestitures, currency issues, and upheaval in Venezuela. Even if the international climate gets more comfortable, the company long known for its pioneering innovation could face competition from generics that could eat into sales.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
Alex Gorsky
CEO Title
Chairman & Chief Executive Officer
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
New Brunswick, NJ
Websitehttp://www.jnj.com
Years on Fortune 500 List23
Employees126,400

Johnson & Johnson Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$71,8902.6%
Profits ($M)$16,5407.3%
Assets ($M)$141,208-
Total Stockholder Equity ($M)$70,418-
Market Value — as of March 31, 2017 ($M)$337,642-

Profit Ratios

Profit as % of Revenues23%
Profits as % of Assets11.7%
Profits as % of Stockholder Equity23.5%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)5.93
EPS % Change (from 2015)8.2%
EPS % Change (5 year annual rate)11.2%
EPS % Change (10 year annual rate)4.7%

Total Return

Total Return to Investors (2016)15.3%
Total Return to Investors (5 year, annualized)15.3%
Total Return to Investors (10 year, annualized)9%